In Stock
Capecitabine Tablets
Capecitabine Tablets 500mg | Anti-Cancer
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic medicine information • For patient education
Product Introduction
Capecitabine 500 mg is a prescription oral chemotherapy medicine classified as an antimetabolite. It is used to treat certain cancers, including breast cancer and cancers of the colon and rectum, either alone or with other cancer medicines.
1. Uses
Treatment of certain types of breast cancer.
Treatment of colon and rectal cancer, including in specific treatment plans after surgery or for advanced disease.
It may be prescribed for other cancer-related indications by an oncologist. The exact regimen depends on the cancer type, stage, previous treatment, and the patient’s health.
2. Benefits
Capecitabine is converted in the body into 5-fluorouracil, which interferes with the production of genetic material needed by cancer cells.
It may slow cancer growth, shrink tumours, help control disease, or reduce the risk of recurrence in selected treatment settings.
Benefits vary by diagnosis and treatment plan; it must be used under specialist supervision.
3. Side Effects
Common side effects include nausea, vomiting, diarrhoea, abdominal pain, tiredness, weakness, reduced appetite, mouth sores, and changes in skin or nails.
Hand-foot syndrome may cause redness, swelling, tingling, pain, or peeling of the palms and soles.
Capecitabine can lower blood-cell counts and may increase infection risk. It can also affect liver or kidney function and, less commonly, cause serious heart problems.
Contact your oncology team urgently for severe or persistent diarrhoea or vomiting, fever or signs of infection, mouth sores that prevent drinking, chest pain, shortness of breath, unusual bleeding, severe hand-foot symptoms, dark urine, or yellowing of the skin or eyes.
4. Safety Advice
Take only as prescribed by your oncologist. Do not change the dose, treatment days, or rest period yourself.
Tell your doctor before treatment if you have kidney or liver disease, heart disease, blood-cell problems, or a history of severe reactions to fluoropyrimidine medicines.
Your doctor may check for DPD (dihydropyrimidine dehydrogenase) deficiency before starting treatment, as deficiency can cause severe or life-threatening toxicity.
Do not use during pregnancy. Discuss effective contraception with your oncology team; both women and men may need contraception during treatment and for a period after the final dose.
Breastfeeding should be avoided during treatment. Ask your doctor before consuming alcohol or driving, particularly if you feel dizzy, weak, or unwell.
Regular blood tests and monitoring of kidney and liver function are important during treatment.
5. How It Works
Capecitabine is converted in the body to 5-fluorouracil (5-FU), which disrupts DNA and RNA synthesis in cancer cells and interferes with their growth and survival.
6. How to Use
Follow the exact dose, schedule, and cycle prescribed by your oncologist; dosing is often based on body size, kidney function, and the treatment plan.
Take tablets with water within 30 minutes after a meal, as directed by the product information.
Swallow tablets whole. Do not crush, chew, or break them unless your oncology team gives specific instructions and appropriate handling procedures.
If you miss a dose or vomit after taking a dose, do not take an extra dose. Contact your oncology team for instructions.
Do not take extra tablets to make up for a missed dose. Never alter treatment days or rest periods without medical advice.
7. Quick Tips
Keep a written record of dose times and treatment-cycle days.
Drink fluids as advised, especially if you have diarrhoea or vomiting; contact your care team early if symptoms persist.
Use gentle skin care and tell your doctor promptly about redness, pain, or peeling of palms or soles.
Keep all scheduled appointments and laboratory tests.
Store below 25°C, away from moisture and out of reach of children. Follow the package label if it gives different storage instructions.
8. Drug Interactions
Tell your doctor and pharmacist about all prescription medicines, over-the-counter products, vitamins, and herbal supplements.
Capecitabine can interact with warfarin and other vitamin K antagonists, potentially causing dangerous bleeding; close monitoring may be needed.
Phenytoin levels may increase when taken with capecitabine. Certain folic-acid/folate products and other anticancer medicines can also affect treatment or toxicity.
Do not start, stop, or change any medicine during chemotherapy without checking with your oncology team.
Medical Disclaimer
This document is for general patient education and is not a substitute for professional medical advice, diagnosis, or treatment. Capecitabine is a cytotoxic prescription chemotherapy medicine. Only the treating oncology team can determine whether it is appropriate and set the dose and cycle. Seek urgent medical advice for severe side effects.
| Product Name | Capecitabine Tablets |
| Category | All Medicines, Anti Cancer |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 500mg |
|---|
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
